Corticosteroid therapy in IgA Nephropathy: A friend or foe?
Background: The administration of corticosteroids in addition to supportive care to delay progressive Immunoglobulin A nephropathy (IgAN), the most common primary glomerulonephritis worldwide, remains controversial. This is partly due to the paucity of well-designed randomized controlled trials and...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2023-03-01
|
| Series: | Kidney & Blood Pressure Research |
| Online Access: | https://www.karger.com/Article/FullText/530285 |